Lidocaine Vs. Lidocaine HCl

CHEMICAL AND PHYSICAL PROPERTIES OF LIDOCAINE AND LIDOCAINE HCL Powder

PCCA currently sells two forms of lidocaine: Lidocaine Hydrochloride USP Monohydrate (PCCA #30-1213) and Lidocaine USP (PCCA #30-1031).

Lidocaine Hydrochloride USP Monohydrate has a molecular weight of 288.81. The molecular structure contains one molecule each of chloride and water. The term “hydrate” refers to “water of hydration.” Water of hydration is water that is stoichiometrically bound into a crystal. You could consider Lidocaine Hydrochloride USP Monohydrate to be the ionized form of lidocaine.

Lidocaine Hydrochloride USP Monohydrate is very water soluble. The pH of an aqueous solution is acidic, often in the range of 4-5. It has a pKa of approximately 7.8. Remember, pKa is the acid dissociation constant, where a molecule exists half in ionized form and half nonionized. What that means to a compounder is that, in an aqueous vehicle, Lidocaine Hydrochloride USP Monohydrate will be half precipitated at a pH of 7.8. As a practical matter, you should be concerned with any pH above 7 since precipitation may start below the pKa value.

Lidocaine USP, sometimes referred to as lidocaine “free base” because it is not bound with chloride and water, has a molecular weight of 234.34. By comparing the molecular weights, you can see a salt ratio of free base to HCl monohydrate salt of 1:1.23. Lidocaine USP is not soluble in water; however, it is soluble in ethyl alcohol and oils. You could consider Lidocaine USP to be the nonionized form of the chemical.

CLINICAL CONSIDERATIONS FOR LIDOCAINE AND LIDOCAINE HCL

Choosing the correct form of lidocaine to use can be challenging. You can gain more insight into this choice by examining lidocaine’s mechanism of action as well as the location of its receptor site on neurons.

Lidocaine acts mainly by inhibiting sodium influx through sodium-specific ion channels in the neuronal cell membrane — in particular, the so-called voltage-gated sodium channels. When the influx of sodium is interrupted, an action potential cannot arise, and the neuron cannot conduct the signal. The receptor site is thought to be located at the cytoplasmic (inner) portion of the sodium channel. Lidocaine Hydrochloride USP Monohydrate binds more readily to sodium channels in an activated state; thus, it tends to take effect faster in rapidly firing neurons. This is referred to as state-dependent blockade. When a patient is in pain, the sodium channels are in an activated state, and the ionized form of lidocaine (Lidocaine Hydrochloride USP Monohydrate) is the best choice.

Conversely, when a patient is not in pain, and you wish to provide anesthesia prior to a pain stimulus, the nonionized form of lidocaine (Lidocaine USP) is the best choice. Since lidocaine’s receptor site is thought to be on the internal surface of the cell membrane, the drug must penetrate the membrane, which is achieved best in the nonionized form. This is most important when applying lidocaine to the surface of skin but not important when applying to mucous membranes.

LEARN MORE